176 related articles for article (PubMed ID: 17414222)
1. Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina.
Fukumoto Y; Mohri M; Inokuchi K; Ito A; Hirakawa Y; Masumoto A; Hirooka Y; Takeshita A; Shimokawa H
J Cardiovasc Pharmacol; 2007 Mar; 49(3):117-21. PubMed ID: 17414222
[TBL] [Abstract][Full Text] [Related]
2. Antianginal effects of hydroxyfasudil, a Rho-kinase inhibitor, in a canine model of effort angina.
Utsunomiya T; Satoh S; Ikegaki I; Toshima Y; Asano T; Shimokawa H
Br J Pharmacol; 2001 Dec; 134(8):1724-30. PubMed ID: 11739249
[TBL] [Abstract][Full Text] [Related]
3. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm.
Mohri M; Shimokawa H; Hirakawa Y; Masumoto A; Takeshita A
J Am Coll Cardiol; 2003 Jan; 41(1):15-9. PubMed ID: 12570938
[TBL] [Abstract][Full Text] [Related]
4. Vasodilatory effect of subsequent administration of fasudil, a rho-kinase inhibitor, surpasses that of nitroglycerin at the concentric coronary stenosis in patients with stable angina pectoris.
Otsuka T; Ibuki C; Suzuki T; Ishii K; Kodani E; Atarashi H; Kishida H; Takano T
Circ J; 2006 Apr; 70(4):402-8. PubMed ID: 16565555
[TBL] [Abstract][Full Text] [Related]
5. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina.
Masumoto A; Mohri M; Shimokawa H; Urakami L; Usui M; Takeshita A
Circulation; 2002 Apr; 105(13):1545-7. PubMed ID: 11927519
[TBL] [Abstract][Full Text] [Related]
6. Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study.
Shimokawa H; Hiramori K; Iinuma H; Hosoda S; Kishida H; Osada H; Katagiri T; Yamauchi K; Yui Y; Minamino T; Nakashima M; Kato K
J Cardiovasc Pharmacol; 2002 Nov; 40(5):751-61. PubMed ID: 12409984
[TBL] [Abstract][Full Text] [Related]
7. Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina.
Otsuka T; Ibuki C; Suzuki T; Ishii K; Yoshida H; Kodani E; Kusama Y; Atarashi H; Kishida H; Takano T; Mizuno K
Coron Artery Dis; 2008 Mar; 19(2):105-10. PubMed ID: 18300747
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of fasudil, a Rho-kinase inhibitor, to treat intractable severe coronary spasm after coronary artery bypass surgery.
Inokuchi K; Ito A; Fukumoto Y; Matoba T; Shiose A; Nishida T; Masuda M; Morita S; Shimokawa H
J Cardiovasc Pharmacol; 2004 Sep; 44(3):275-7. PubMed ID: 15475822
[TBL] [Abstract][Full Text] [Related]
9. Effects of fasudil, a Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats.
Demiryürek S; Kara AF; Celik A; Babül A; Tarakçioglu M; Demiryürek AT
Eur J Pharmacol; 2005 Dec; 527(1-3):129-40. PubMed ID: 16307738
[TBL] [Abstract][Full Text] [Related]
10. Variable responses of highly stenotic coronary arteries and collateral circulation to intracoronary injection of nitroglycerin in patients with chronic effort angina.
Fujita M; Yamanishi K; Miwa K; Inoko M
Coron Artery Dis; 1994 Jun; 5(6):525-9. PubMed ID: 7952412
[TBL] [Abstract][Full Text] [Related]
11. Antiischemic properties of fasudil in experimental models of vasospastic angina.
Sato S; Ikegaki I; Asano T; Shimokawa H
Jpn J Pharmacol; 2001 Sep; 87(1):34-40. PubMed ID: 11676196
[TBL] [Abstract][Full Text] [Related]
12. Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo.
Shimokawa H; Morishige K; Miyata K; Kandabashi T; Eto Y; Ikegaki I; Asano T; Kaibuchi K; Takeshita A
Cardiovasc Res; 2001 Jul; 51(1):169-77. PubMed ID: 11399259
[TBL] [Abstract][Full Text] [Related]
13. Effects of intracoronary infusion of atrial natriuretic peptide on pacing-induced myocardial ischemia in patients with effort angina pectoris.
Kai H; Egashira K; Hirooka Y; Sugimachi M; Suzuki S; Kuga T; Mohri K; Urabe Y; Inou T; Takeshita A
Coron Artery Dis; 1994 Dec; 5(12):987-94. PubMed ID: 7728299
[TBL] [Abstract][Full Text] [Related]
14. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases.
Shimokawa H
J Cardiovasc Pharmacol; 2002 Mar; 39(3):319-27. PubMed ID: 11862109
[TBL] [Abstract][Full Text] [Related]
15. Coronary Functional Abnormalities in Patients With Angina and Nonobstructive Coronary Artery Disease.
Suda A; Takahashi J; Hao K; Kikuchi Y; Shindo T; Ikeda S; Sato K; Sugisawa J; Matsumoto Y; Miyata S; Sakata Y; Shimokawa H
J Am Coll Cardiol; 2019 Nov; 74(19):2350-2360. PubMed ID: 31699275
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial.
Vicari RM; Chaitman B; Keefe D; Smith WB; Chrysant SG; Tonkon MJ; Bittar N; Weiss RJ; Morales-Ballejo H; Thadani U;
J Am Coll Cardiol; 2005 Nov; 46(10):1803-11. PubMed ID: 16286163
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of Rho-kinase by fasudil preventing anginal attacks associated with spastic angina: a case report].
Hiroki J; Fukumoto Y; Shimokawa H; Hirooka Y; Takeshita A
J Cardiol; 2004 Oct; 44(4):161-4. PubMed ID: 15532247
[TBL] [Abstract][Full Text] [Related]
19. Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease.
Nohria A; Grunert ME; Rikitake Y; Noma K; Prsic A; Ganz P; Liao JK; Creager MA
Circ Res; 2006 Dec; 99(12):1426-32. PubMed ID: 17095725
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
Nishikimi T; Koshikawa S; Ishikawa Y; Akimoto K; Inaba C; Ishimura K; Ono H; Matsuoka H
J Hypertens; 2007 May; 25(5):1053-63. PubMed ID: 17414670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
